Poland
· Delayed Price · Currency is PLN Medicalgorithmics Company Description
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally.
It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices.
The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis.
In addition, it operates ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal based on deep learning methods.
In addition, the company engages in the provision of information technology and ECG monitoring services; research and development, including the development of artificial intelligence (AI) algorithms and software for arrhythmia diagnostics, as well as the development and commercialization of AI-based VCAST cardiac imaging technology; and production of electromedical equipment.
Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.
| Country | Poland |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 117 |
| CEO | Krzysztof Siemionow |
Contact Details
Address: Central Tower Building Warsaw, 02-001 Poland | |
| Phone | 48 22 825 1249 |
| Website | medicalgorithmics.pl |
Stock Details
| Ticker Symbol | MDG |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMDCLG00015 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Krzysztof Siemionow M.D., Ph.D. | President of the Management Board and Chief Executive Officer |
| Jaroslaw Jerzakowski | Chief Operating Officer |
| Przemyslaw Tadla | Chief Technology Officer |
| Michal Zapora | Chief Financial Officer and Member of the Management Board |
| Linda S Johnson | Chief Scientific Officer |
| Katarzyna Perzak | Director of Investor Relations |
| Catalina Barrero Guzman | Marketing Manager |